217730 — Kang Stem Biotech Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩145bn
- KR₩123bn
- KR₩13bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,005 | 9,138 | 12,405 | 16,301 | 12,704 |
Cost of Revenue | |||||
Gross Profit | -424 | 1,046 | 2,689 | 4,873 | 1,643 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 33,083 | 29,527 | 35,127 | 36,652 | 35,729 |
Operating Profit | -27,079 | -20,389 | -22,722 | -20,351 | -23,025 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -26,302 | -19,756 | -21,811 | -20,215 | -23,137 |
Provision for Income Taxes | |||||
Net Income After Taxes | -26,394 | -19,746 | -21,827 | -20,176 | -23,221 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -24,635 | -18,471 | -21,348 | -20,236 | -21,949 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -24,635 | -18,471 | -21,348 | -20,236 | -21,949 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -845 | -622 | -726 | -489 | -538 |
Dividends per Share |